• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TMPRSS2:ERG相关的循环抗氧化剂水平与前列腺癌风险

Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG.

作者信息

Graff Rebecca E, Judson Gregory, Ahearn Thomas U, Fiorentino Michelangelo, Loda Massimo, Giovannucci Edward L, Mucci Lorelei A, Pettersson Andreas

机构信息

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.

出版信息

Prostate. 2017 May;77(6):647-653. doi: 10.1002/pros.23312. Epub 2017 Jan 19.

DOI:10.1002/pros.23312
PMID:28102015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5354965/
Abstract

BACKGROUND

Few studies have considered etiological differences across molecular subtypes of prostate cancer, despite potential to improve opportunities for precision prevention of a disease for which modifiable risk factors have remained elusive. Factors that lead to DNA double-strand breaks, such as oxidative stress, may promote the formation of the TMPRSS2:ERG gene fusion in prostate cancer. We tested the hypothesis that increasing levels of pre-diagnostic circulating antioxidants, which may reduce oxidative stress, are associated with lower risk of developing TMPRSS2:ERG positive prostate cancer.

METHODS

We conducted a nested case-control study, including 370 cases and 2,470 controls, to evaluate associations between pre-diagnostic α- and β-carotene, α- and γ-tocopherol, β-cryptoxanthin, lutein, lycopene, retinol, and selenium with the risk of prostate cancer by ERG protein expression status (a marker of TMPRSS2:ERG). Multivariable unconditional polytomous logistic regression was used to calculate odds ratios and 95% confidence intervals.

RESULTS

We did not find any of the antioxidants to be significantly associated with the risk of prostate cancer according to ERG status.

CONCLUSIONS

The results do not support the hypothesis that circulating pre-diagnostic antioxidant levels protect against developing TMPRSS2:ERG positive prostate cancer. Additional studies are needed to explore mechanisms for the development of TMPRSS2:ERG positive disease. Prostate 77: 647-653, 2017. © 2017 Wiley Periodicals, Inc.

摘要

背景

尽管有可能改善前列腺癌精准预防的机会,但很少有研究考虑前列腺癌分子亚型的病因差异,而前列腺癌的可改变风险因素一直难以捉摸。导致DNA双链断裂的因素,如氧化应激,可能促进前列腺癌中TMPRSS2:ERG基因融合的形成。我们检验了这样一个假设,即增加诊断前循环抗氧化剂水平(这可能降低氧化应激)与降低发生TMPRSS2:ERG阳性前列腺癌的风险相关。

方法

我们进行了一项巢式病例对照研究,包括370例病例和2470例对照,以评估诊断前α-和β-胡萝卜素、α-和γ-生育酚、β-隐黄质、叶黄素、番茄红素、视黄醇和硒与ERG蛋白表达状态(TMPRSS2:ERG的标志物)相关的前列腺癌风险之间的关联。采用多变量无条件多分类逻辑回归计算比值比和95%置信区间。

结果

根据ERG状态,我们未发现任何一种抗氧化剂与前列腺癌风险有显著关联。

结论

结果不支持以下假设,即诊断前循环抗氧化剂水平可预防TMPRSS2:ERG阳性前列腺癌的发生。需要进一步研究来探索TMPRSS2:ERG阳性疾病的发病机制。《前列腺》77: 647 - 653, 2017。© 2017威利期刊公司。

相似文献

1
Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG.TMPRSS2:ERG相关的循环抗氧化剂水平与前列腺癌风险
Prostate. 2017 May;77(6):647-653. doi: 10.1002/pros.23312. Epub 2017 Jan 19.
2
Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression.根据ERG肿瘤蛋白表达情况,分析诊断前循环性激素水平与前列腺癌风险的关系。
Br J Cancer. 2016 Apr 12;114(8):939-44. doi: 10.1038/bjc.2016.61. Epub 2016 Mar 17.
3
A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG.一项关于体力活动与临床特征和 TMPRSS2:ERG 定义的前列腺癌风险之间关联的前瞻性研究。
Eur Urol. 2019 Jul;76(1):33-40. doi: 10.1016/j.eururo.2018.09.041. Epub 2018 Oct 6.
4
Urine TMPRSS2:ERG fusion transcript integrated with PCA3 score, genotyping, and biological features are correlated to the results of prostatic biopsies in men at risk of prostate cancer.尿液 TMPRSS2:ERG 融合转录本与 PCA3 评分、基因分型和生物学特征相结合,与前列腺癌高危男性前列腺活检结果相关。
Prostate. 2013 Feb 15;73(3):242-9. doi: 10.1002/pros.22563. Epub 2012 Jul 20.
5
Calcium Channel Blocker Use and Risk of Prostate Cancer by TMPRSS2:ERG Gene Fusion Status.钙通道阻滞剂的使用与TMPRSS2:ERG基因融合状态相关的前列腺癌风险
Prostate. 2017 Feb;77(3):282-290. doi: 10.1002/pros.23267. Epub 2016 Oct 18.
6
Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer.前列腺癌男性尿液中TMPRSS2:ERG融合转录本的无创检测
Neoplasia. 2006 Oct;8(10):885-8. doi: 10.1593/neo.06625.
7
Obesity and Prostate Cancer Risk According to Tumor TMPRSS2:ERG Gene Fusion Status.根据肿瘤TMPRSS2:ERG基因融合状态分析肥胖与前列腺癌风险
Am J Epidemiol. 2015 May 1;181(9):706-13. doi: 10.1093/aje/kwu344. Epub 2015 Apr 7.
8
Morphological features of TMPRSS2-ERG gene fusion prostate cancer.TMPRSS2-ERG基因融合前列腺癌的形态学特征。
J Pathol. 2007 May;212(1):91-101. doi: 10.1002/path.2154.
9
Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis.血浆番茄红素水平升高的男性患前列腺癌风险较低:一项前瞻性分析的结果
Cancer Res. 1999 Mar 15;59(6):1225-30.
10
Height, Obesity, and the Risk of -Defined Prostate Cancer.身高、肥胖与特定类型前列腺癌风险的关系。
Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):193-200. doi: 10.1158/1055-9965.EPI-17-0547. Epub 2017 Nov 22.

引用本文的文献

1
Association of Lutein with Cancer: A Systematic Review of the Lutein Effects on Cellular Processes Involved in Cancer Progression.叶黄素与癌症的关联:叶黄素对癌症进展相关细胞过程影响的系统综述
Prev Nutr Food Sci. 2025 Jun 30;30(3):250-262. doi: 10.3746/pnf.2025.30.3.250.
2
Etiology of prostate cancer with the TMPRSS2:ERG fusion: A systematic review of risk factors.伴有TMPRSS2:ERG融合的前列腺癌病因:危险因素的系统评价
Int J Cancer. 2025 May 15;156(10):1898-1908. doi: 10.1002/ijc.35279. Epub 2024 Dec 11.
3
Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19.炎症的表观遗传学基础:连接肺部疾病、肺癌和 COVID-19 之间的联系。
Semin Cancer Biol. 2022 Aug;83:384-398. doi: 10.1016/j.semcancer.2021.01.003. Epub 2021 Jan 20.
4
Serum Retinol and Risk of Overall and Site-Specific Cancer in the ATBC Study.血清视黄醇与 ATBC 研究中总体和特定部位癌症风险的关系。
Am J Epidemiol. 2020 Jun 1;189(6):532-542. doi: 10.1093/aje/kwz226.
5
Effect of lycopene supplementation on cardiovascular parameters and markers of inflammation and oxidation in patients with coronary vascular disease.补充番茄红素对冠心病患者心血管参数以及炎症和氧化标志物的影响。
Food Sci Nutr. 2018 Aug 13;6(6):1770-1777. doi: 10.1002/fsn3.734. eCollection 2018 Sep.
6
Nutraceuticals in prostate cancer therapeutic strategies and their neo-adjuvant use in diverse populations.营养保健品在前列腺癌治疗策略中的应用及其在不同人群中的新辅助应用。
NPJ Precis Oncol. 2018 Jul 25;2:15. doi: 10.1038/s41698-018-0058-x. eCollection 2018.
7
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.

本文引用的文献

1
Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation in Prostate Cancer.炎症诱导的氧化应激介导前列腺癌中的基因融合形成。
Cell Rep. 2016 Dec 6;17(10):2620-2631. doi: 10.1016/j.celrep.2016.11.019.
2
Dietary lycopene intake and risk of prostate cancer defined by ERG protein expression.膳食番茄红素摄入量与由ERG蛋白表达定义的前列腺癌风险
Am J Clin Nutr. 2016 Mar;103(3):851-60. doi: 10.3945/ajcn.115.118703. Epub 2016 Jan 27.
3
The Molecular Taxonomy of Primary Prostate Cancer.原发性前列腺癌的分子分类学
Cell. 2015 Nov 5;163(4):1011-25. doi: 10.1016/j.cell.2015.10.025.
4
Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status.阿司匹林和非甾体抗炎药的使用与由TMPRSS2:ERG融合状态定义的前列腺癌分子亚型的关系。
Prostate Cancer Prostatic Dis. 2016 Mar;19(1):53-6. doi: 10.1038/pcan.2015.49. Epub 2015 Oct 27.
5
Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies.类胡萝卜素、视黄醇、生育酚与前列腺癌风险:15项研究的汇总分析
Am J Clin Nutr. 2015 Nov;102(5):1142-57. doi: 10.3945/ajcn.115.114306. Epub 2015 Oct 7.
6
Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.血浆抗氧化剂、超氧化物歧化酶2(SOD2)、过氧化氢酶(CAT)、谷胱甘肽过氧化物酶1(GPX1)、谷胱甘肽过氧化物酶4(GPX4)的基因变异与前列腺癌生存率
Cancer Epidemiol Biomarkers Prev. 2014 Jun;23(6):1037-46. doi: 10.1158/1055-9965.EPI-13-0670. Epub 2014 Apr 7.
7
Microenvironmental regulation of tumor progression and metastasis.肿瘤演进和转移的微环境调控。
Nat Med. 2013 Nov;19(11):1423-37. doi: 10.1038/nm.3394.
8
The TMPRSS2:ERG rearrangement, ERG expression, and prostate cancer outcomes: a cohort study and meta-analysis.TMPRSS2:ERG 重排、ERG 表达与前列腺癌结局:一项队列研究和荟萃分析。
Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1497-509. doi: 10.1158/1055-9965.EPI-12-0042. Epub 2012 Jun 26.
9
Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.免疫组织化学法检测 ERG 表达可作为前列腺腺癌中 TMPRSS2-ERG 融合检测的替代方法。
Am J Surg Pathol. 2011 Jul;35(7):1014-20. doi: 10.1097/PAS.0b013e31821e8761.
10
Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.抗体 EPR3864 特异性识别前列腺癌中的 ERG 基因组融合:对病理实践的影响。
Mod Pathol. 2011 Aug;24(8):1128-38. doi: 10.1038/modpathol.2011.65. Epub 2011 Apr 15.